Children's Hospital of Los Angeles

Total Awards: 
Award Value: 
Institution type: 
Not for profit
Short Name: 

Awards to the Institution

Program Investigator Award Title Award Value
Training Grant I-2 Donald Kohn Training Grant 1 $2,173,872
Clinical Trial Stage Projects Michael Pulsipher Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES) $4,825,587
New Faculty Physician Scientist Tracy Grikscheit The generation and expansion of tissue-engineered small intestine from human stem/ progenitor cells: a preclinical study of functional translation $3,146,160
Quest - Discovery Stage Research Projects Mark Frey Universal Pluripotent Liver Failure Therapy (UPLiFT) $1,297,512
Disease Team Planning Donald Kohn STEM CELL GENE THERAPY FOR SICKLE CELL DISEASE $12,131
Research Training Grant Ching-Ling Lien CIRM Training Program for Stem Cell and Regenerative Medicine Research $4,999,500
Comprehensive Grant Gay Crooks Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC) $575,994
SPARK Mark Frey Stem Cell and Regenerative Medicine Summer Internships for High School Students from Under-Served Communities $508,750
SEED Grant Elizabeth Lawlor hESC as tools to investigate the neural crest origin of Ewing's sarcoma $595,576
Shared Labs Carolyn Lutzko The Childrens Hospital of Los Angeles hESC Facility $1,684,648
New Faculty II Tracy Grikscheit Mechanism of Tissue Engineered Small Intestine Formation $3,211,122
Early Translational II Markus Muschen Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication $850,769
Shared Labs David Warburton The Childrens Hospital of Los Angeles hESC Facility $1,750,259
Therapeutic Translational Research Projects Mark Frey ASCENT- Advanced Stem Cell Enteric Neuropathy Therapy $7,077,352
Research Training II David Warburton CHLA Stem Cell Training Grant $5,020,920
Inception - Discovery Stage Research Projects Senta Georgia Developing a personalized approach to beta cell replacement for patients with a genetic form of diabetes $179,995
Icon for XLSX export